HomeInsightsStock Comparison

Eris Lifesciences Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Eris Lifesciences Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jun 20, 2025

Key Highlights

  • The Latest Trading Price of ERIS Lifesciences Ltd is ₹ 1704 as of 20 Jun 12:37.
  • The P/E Ratio of ERIS Lifesciences Ltd changed from 16.9 on March 2020 to 29.2 on March 2024 . This represents a CAGR of 11.56% over 5 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 32.6 on March 2020 to 53.2 on March 2024 . This represents a CAGR of 10.29% over 5 years.
  • The Market Cap of ERIS Lifesciences Ltd changed from ₹ 5003 crore on March 2020 to ₹ 11442 crore on March 2024 . This represents a CAGR of 17.99% over 5 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 33361 crore on March 2020 to ₹ 88030 crore on March 2024 . This represents a CAGR of 21.42% over 5 years.
  • The revenue of ERIS Lifesciences Ltd for the Mar '25 is ₹ 713.31 crore as compare to the Dec '24 revenue of ₹ 731.67 crore. This represent the decline of -2.51% The revenue of Torrent Pharmaceuticals Ltd for the Mar '25 is ₹ 2941 crore as compare to the Dec '24 revenue of ₹ 2842 crore. This represent the growth of 3.48%.
  • The ebitda of ERIS Lifesciences Ltd for the Mar '25 is ₹ 260.4 crore as compare to the Dec '24 ebitda of ₹ 254.53 crore. This represent the growth of 2.31% The ebitda of Torrent Pharmaceuticals Ltd for the Mar '25 is ₹ 922 crore as compare to the Dec '24 ebitda of ₹ 947 crore. This represent the decline of -2.64%.
  • The net profit of ERIS Lifesciences Ltd changed from ₹ 93.65 crore to ₹ 102.35 crore over 8 quarters. This represents a CAGR of 4.54% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 378 crore to ₹ 498 crore over 8 quarters. This represents a CAGR of 14.78% .
  • The Dividend Payout of ERIS Lifesciences Ltd changed from 13.76 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 57.71 % on March 2020 to 69.83 % on March 2024 . This represents a CAGR of 3.89% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About ERIS Lifesciences Ltd

  • Eris Lifesciences Limited was incorporated on January 25, 2007.
  • Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007.
  • Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on February 2, 2017.
  • The Company has a manufacturing plant in Guwahati, Assam and is presently engaged in manufacturing and marketing of pharmaceutical products.
  • It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors.

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
  • The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 12 countries with major setups in the US, Germany and Brazil.

ERIS Lifesciences Ltd News Hub

News

Eris Lifesciences gains after Q4 PAT climbs 32% YoY to Rs 94 cr

Profit before tax (PBT) climbed 67.9% YoY to Rs 128.87 crore in Q4 FY25. During the quarte...

Read more

20 May 2025 13:08

News

ERIS Lifesciences to hold board meeting

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 19 May 2...

Read more

14 May 2025 16:22

News

Eris Lifesciences allots 33,287 equity shares under ESOP

Eris Lifesciences has allotted 33,287 equity shares under ESOP on 06 March 2025. The paid-...

Read more

06 Mar 2025 13:17

News

Eris Lifesciences avails credit facility of Rs 1,000 cr

Eris Lifesciences has availed credit facilities amounting to Rs 1000 crore from Kotak Mahi...

Read more

21 Feb 2025 09:22

News

Board of ERIS Lifesciences recommends Interim Dividend

ERIS Lifesciences announced that the Board of Directors of the Company at its meeting held...

Read more

07 Feb 2025 16:36

News

ERIS Lifesciences schedules board meeting

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 7 Februa...

Read more

05 Feb 2025 14:58

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharmaceuticals Ltd spurts 0.03%, gains for five straight sessions

Torrent Pharmaceuticals Ltd rose for a fifth straight session today. The stock is quoting ...

Read more

09 Jun 2025 13:00

News

Board of Torrent Pharmaceuticals recommends final dividend

Torrent Pharmaceuticals announced that the Board of Directors of the Company at its meetin...

Read more

20 May 2025 20:32

News

Torrent Pharmaceuticals to conduct board meeting

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 20...

Read more

14 May 2025 14:06

News

Torrent Pharmaceuticals announces resignation of ED (Strategic Planning)

Torrent Pharmaceuticals announced that Pranav Mehta, Executive Director (Strategic Plannin...

Read more

27 Feb 2025 18:47

News

Torrent Pharmaceuticals Ltd rises for third consecutive session

Torrent Pharmaceuticals Ltd gained for a third straight session today. The stock is quotin...

Read more

07 Feb 2025 13:05

News

Torrent Pharmaceuticals Ltd slips for fifth straight session

Torrent Pharmaceuticals Ltd is down for a fifth straight session today. The stock is quoti...

Read more

04 Feb 2025 13:35

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of ERIS Lifesciences Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Torrent Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for ERIS Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of ERIS Lifesciences Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, ERIS Lifesciences Ltd or Torrent Pharmaceuticals Ltd?

Market cap of ERIS Lifesciences Ltd is 23,633 Cr while Market cap of Torrent Pharmaceuticals Ltd is 107,213 Cr

What are the key factors driving the stock performance of ERIS Lifesciences Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of ERIS Lifesciences Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for ERIS Lifesciences Ltd and Torrent Pharmaceuticals Ltd?

As of June 20, 2025, the ERIS Lifesciences Ltd stock price is INR ₹1735.25. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹3167.95.

How do dividend payouts of ERIS Lifesciences Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of ERIS Lifesciences Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions